|
|
|
Volumn 24, Issue 5 SUPPL. 17, 1997, Pages
|
|
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with Metastatic breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
METHOTREXATE;
MITOXANTRONE;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
ADULT;
BREAST CANCER;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIARRHEA;
DRUG MEGADOSE;
FEMALE;
HEART MUSCLE BIOPSY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAXIMUM PERMISSIBLE DOSE;
MUCOSA INFLAMMATION;
NEUTROPENIA;
PRIORITY JOURNAL;
ARTICLE;
BREAST TUMOR;
DRUG ADMINISTRATION;
DRUG EFFECT;
HEART;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
LUNG FUNCTION TEST;
METASTASIS;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEART;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
PACLITAXEL;
RESPIRATORY FUNCTION TESTS;
|
|
EID: 0031254769
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (11)
|
